期刊文献+

二氮嗪治疗无效的先天性高胰岛素血症3例家系KCNJ11基因突变分析 被引量:8

KCNJ11 mutation in 3 children with diazoxide-unresponsive congenital hyperinsulinism
原文传递
导出
摘要 目的对3例二氮嗪治疗无效的先天性高胰岛素血症患儿及其家系进行KCNJ11基因突变分析,初步探讨中国儿童腺嘌呤核苷三磷酸敏感性钾通道型高胰岛素血症的发病机制。方法以2008年1月至2009年12月我院收治的3例二氮嗪治疗无效的先天性高胰岛素血症患儿及其家系为研究对象,采用聚合酶链反应DNA直接测序法对3例患儿及其亲属进行KCNJ11基因测序分析。结果于第1例患儿及其父亲的KCNJ11基因外显子中分别发现1个703C〉G(Q235E)杂合失活突变,患儿母亲该位点基因型正常(C/C)。未发现第2、3例患儿家系中出现KCNJ11基因突变。结论KCNJ11基因Q235E突变可以导致腺嘌呤核苷三磷酸敏感性钾通道型先天性高胰岛素血症的发生,少数常染色体显性遗传KCNJ11基因突变所致的腺嘌呤核苷三磷酸敏感性钾通道型先天性高胰岛素血症对二氮嗪治疗无效。 Objective To investigate KCNJ11 gene mutation in three children with diazoxideunresponsive congenital hyperinsulinism (CHI) so as to identify genetic mechanism of ATP-sensitive K + channel-hyperinsulinism (KATP-HI) in Chinese children. Methods Three children with diazoxideunresponsive CHI and their parents were selected as subjects from January 2008 to December 2009. Polymerase chain reaction (PCR)-DNA direct sequencing was used to analyze the exon of the KCNJ11 gene. Results In case 1, a Q235E heterozygous inactivation mutation was found in KCNJ11 gene, although the genotype of the mother was normal ( C/C ). No mutations were detected in case 2 and 3. Conclusion KCNJ11 Q235E mutation could lead to the onset of KATP-HI. Minority of patients with autosomal dominant KCNJ11 mutation may be unresponsive to diazoxide treatment.
出处 《中华糖尿病杂志》 CAS 2012年第5期270-273,共4页 CHINESE JOURNAL OF DIABETES MELLITUS
关键词 高胰岛素血症 二氮嗪 基因 钾通道 Hyperinsulinism Diazoxide Genes Potassium channels
  • 相关文献

参考文献13

  • 1De-Leon DD,Stanley CA. Mechanisms of disease:advances in diagnosis and treatment of hyperinsulinism in neonates[J].Endocrinology and Metabolism,2007.57-68.
  • 2Kapoor RR,James C,Flanagan SE. 3-Hydroxyacylcoenzyme a debydrogenase deficiency and hyperinsulinemic hypoglycemia:characterization of a novel mutation and severe dietary protein sensitivity[J].J Clinic Endocrinol Metabo,2009.2221-2225.
  • 3Bellanné-Chnatelot C,Saint-Martin C,Ribeiro M J. ABCC8 and KCNJ11 molecular spectrum of 109 patients with diazoxideunresponsive congenital hyperinsulinism[J].Journal of Medical Genetics,2010.752-759.
  • 4Marquard J,Palladino AA,Stanley CA. Rare forms of congenital hyperinsulinism[J].Seminars in Pediatric Surgery,2011.38-44.doi:10.1053/j.sempedsurg.2010.10.006.
  • 5Hussain K. Diagnosis and management of hyperinsluinaemic hypoglycaemia of infancy[J].Hormone Research,2008,(1):2-13.doi:10.1159/000111789.
  • 6桑艳梅,倪桂臣,刘桂琴,刘敏,谷奕.三例谷氨酸脱氢酶型先天性高胰岛素血症患儿的GLUD1基因突变分析[J].中华医学遗传学杂志,2010,27(5):493-496. 被引量:4
  • 7Flanagan SE,Kapoor RR,Hussain K. Genetics of congenital hyperinsulinemic hypoglycemia[J].Seminars in Pediatric Surgery,2011.13-17.
  • 8Lovisolo SM,Mendon(c)a BB,Pinto EM. Congenital hyperinsulinism in Brazilian neonates:a study of histology,KATP channel genes,and proliferation of β cells[J].Pediatric and Developmental Pathology,2010.375-384.doi:10.2350/08-12-0578.1.
  • 9Saint-Martin C,Arnoux JB,de Lonlay P. KATP channel mutations in congenital hyperinsulinism[J].Seminars in Pediatric Surgery,2011.18-22.
  • 10桑艳梅,苞山.先天性高胰岛素血症的遗传发病机制及诊疗进展[J].中国糖尿病杂志,2009,17(9):713-715. 被引量:13

二级参考文献13

  • 1Diva D De Leon, Stanley CA. Mechanism of Disease: advances in diagnosis and treatment of hyperinsulinism in neonates. Nature Clinical Practice Endocrinology and Metabolism, 2007, 3 : 57 68.
  • 2Gloyn AL,Siddiqui J and Ellard S. Mutations is the Genes Encoding the Pancreatic Beta-cell KATP Channel Subunits Kir6.2 (KCNJ11) and SURI(ABCC8) in Diabetes Mellitus and Hyperinsulinism, Human Mutation, 2006, 27 : 220-231.
  • 3Cuesta-Munoz AL, Huopio H, Otonkoski T, et al. Severe persistent hyperinsulinemic hypoglycemia due to a de novo glueokinase mutation. Diabetes, 2004,53 : 2164 -2168.
  • 4YanFF, Lin YW, MacMullen C,et al. Congenital hyperinsulinism associated ABCC8 mutations that cause defective trafficking of ATP-sensitive K+ channels:identification and rescue. Diabetes, 2007,56 : 2339-2348.
  • 5Lin YW,Bushman ID,Yan FF, et al. Destabilization of ATP sensitive potassium channel activity by novel KCNJ11 mutations identified in congenital hyperinsulinism. J Biol Chem, 2008,283 9146-9156.
  • 6Stanley CA, Thornton PS, Ganguly A, et al. Preoperative evaluation of infants with focal or diffuse congenital hyperinsulinism by intravenous acute insulin response tests and selective pancreatic arterial calcium stimulation. J Clin Endocrinol Metab, 2004,89: 288- 296.
  • 7Stanley CA,Lieu YK, Hsu BYL, et al. Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl J Med, 1998,338 : 226-230.
  • 8Dunne MJ, Cosgrove KE,Shepherd RM,et al. Hyperinsulinism in infancy: from basic science to clinical disease. Physiol Rev, 2004,84:239-275.
  • 9Li CH, Matter A, Kelly Andrea, et al. Effects of a GTP insensitive mutation of glutamate dehydrogenase on insulin secretion in transgenic mice. J Biol Chem, 2006,281 : 15064- 15072.
  • 10Christesen HBT, Herold K, Noordam C, et al. Glucokinase and glycemic disease:from basics to novel therapeutics. Front Diabetes, Basal, Karger, 2004,16 : 75- 91.

共引文献15

同被引文献62

  • 1James C, Kalooor RR, lsmai| D, et al. The genetic basis of congenital hyperinsulinism. J Med Genet,2009 ,46 :289-299.
  • 2Marquard J, Palladino AA, Stanley CA, et al. Rare forms of congenital hyperinsulinism. Semin Pediatr Surg, 2011, 20, 38-44.
  • 3Banerjee I, Shake M, Flanagan SE, et al. The contribution of rapid KATP channel gene mutation analysis to the clinical management of children with congenital hyperinsulinism. Eur J Endoerinol, 2011,164:733-740.
  • 4Henpuin JC, Nenquin M, Sempoux C, et al. In vitro insulin secretion by pancreatic tissue from infants with diazoxide-resistant congenital hyperinsulinism deviates from model predictions. J Clin Invest,2011,121 : 3932 -3942.
  • 5Damaj L, le Loreh M, Verkarre V, et al. Chromosome llp15 paternal isodisomy in focal forms of neonatal hyperinsulinism. J Clin Endocrinol Metab. 2008.93:4941-4947.
  • 6Powell PD, Bellanno-Chantelot C, Flanagan SE, et al. In vitro recovery of atp-sensitive potassium channels in G-cells from patients with congenital hyperinsulinism of infancy. Diabetes, 2011, 60 : 1223-1228.
  • 7Mannikko R, Flanagan SE, Sim X, et al. Mutations of the same conserved glutamate residue in NBD2 of the sulfonylurea receptorl subunit of the KATP channel can result in either hyperinsulinism or neonatal diabetes. Diabetes, 2011, 60:1813-1822.
  • 8Pinney SE, MacMullen C, Becker S, et al. Clinical characteristics and biochemical mechanisms of congenital hyperinsulinism associated with dominant KATP channel mutations. J Clin Invest, 2008, 118:2877-2886.
  • 9James C, Kapoor RR, Ismall D, et al. The genetic basis of congenital hyperinsulinism. J Med Genet, 2009, 46:289-299.
  • 10Stanley CA, Lieu YK, Hsu BY, et al. Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl J Med, 1998, 338: 226-230.

引证文献8

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部